Improvement of cutaneous microcirculation and oxygen supply in patients with chronic venous insufficiency by orally administered extract of red vine leaves AS 195: A randomised, double-blind, placebo-controlled, crossover study

Drugs in R and D

Volumn 5, Issue 2, 2004, Pages 63-71

  Kalus, Ulrich ^a   Koscielny, Juergen ^a   Grigorov, Alexandre ^a   Schaefer, Eckhard ^b   Peil, Hubertus ^b   Kiesewetter, Holger ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISTAX; AS 195; OXYGEN; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE CLASSIFICATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ELECTRODE; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; LEG EDEMA; MALE; MEDICINAL PLANT; MICROCIRCULATION; OXYGEN SUPPLY; PATIENT SELECTION; PLANT LEAF; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RED VINE; SIDE EFFECT; SKIN BLOOD FLOW; SOLID STATE; TRANSCUTANEOUS OXYGEN MONITORING; VEIN INSUFFICIENCY;

ADULT; AGED; BLOOD GAS MONITORING, TRANSCUTANEOUS; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; SKIN; VENOUS INSUFFICIENCY; VITIS;

EID: 2342553510     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200405020-00001     Document Type: Article

References (19)

1. Van den Oever R, Hepp B, Debbaut B, et al. Socio-economic impact of chronic venous insufficiency: an underestimated public health problem. Int Angiol 1998; 17 (3): 161-7
2. Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology 2001; 52 Suppl. 1: S5-15
3. Frick RW. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon. Angiology 2000; 51 (3): 197-205
4. Kiesewetter H, Koscielny J, Kalus U, et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II): a randomized, double-blind, placebo-controlled trial. Arzneimittel Forschung 2000; 50 (2): 109-17
5. Antignani PL. Classification of chronic venous insufficiency: a review. Angiology 2001; 52 Suppl. 1: S17-26
6. Doerschel K, Müller GJ. PC-integrated laser doppler blood flow measurements in skin. In: Farkas DL, Leif RC, Priezzhev AV, et al., editors. Proceedings of the International Society for Optical Engineering (SPIE) 1996; 2678: 382-8
7. Fagrell B. Advances in microcirculation network evaluation: an update. Int J Microcirc Clin Exp 1995; 15 Suppl. 1: S34-40
8. Bollinger A, Jager K, Juenger M, et al. The vascular laboratory: advances in noninvasive techniques. World J Surg 1988; 12 (6): 724-31
9. Diehm C, Trampisch HJ, Lange S, et al. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 1996; 347 (8997): 292-4
10. Struckmann JR. Clinical efficacy of micronized purified flavonoid fraction: an overview. J Vasc Res 1999; 36 Suppl. 1: S37-41
11. Ramelet AA. Clinical benefits of Daflon 500mg in the most severe stages of chronic venous insufficiency. Angiology 2001; 52 Suppl. 1: S49-56
12. Bergan JJ, Schmid-Schoenbein GW, Takase S. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500mg. Angiology 2001; 52 Suppl. 1: S43-7
13. Signorelli SS, Malaponte MG, Di Pino L, et al. Venous stasis causes release of interleukin 1beta (IL-1beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFalpha) by monocyte-macrophage. Clin Hemorheol Microcirc 2000; 22 (4): 311-6
14. Coleridge Smith PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology 2001; 52 Suppl. 1: S35-42
15. Schmid-Schoenbein GW, Takase S, Bergan JJ. New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology 2001; 52 Suppl. 1: S27-34
16. Nees S, Weiss DR, Reichenbach-Klinke E, et al. Protective effects of flavonoids contained in the red vine leaf on venular endothelium against the attack of activated blood components in vitro. Arzneimittel Forschung 2003; 53 (5): 330-41
17. Bollinger A, Leu AJ, Hoffmann U, et al. Microvascular changes in venous disease: an update. Angiology 1997; 48 (1): 27-32
18. Tulevski II, Ubbink DT, Jacobs MJ. Red and green laser Doppler compared with capillary microscopy to assess skin microcirculation in the feet of healthy subjects. Microvasc Res 1999; 58 (2): 83-8
19. Cesarone MR, De Sanctis MT, Incandela L, et al. Methods of evaluation and quantification of microangiopathy in high perfusion microangiopathy (chronic venous insufficiency and diabetic microangiopathy). Angiology 2001; 52 Suppl. 2: S3-7